The authors have repeated the Western blot analysis of the entire set of chimpanzee fecal samples reported in the study. Specifically, they went back to the original fecal specimens (which were stored at -80˚C), took another 1.5 ml aliquot from each sample, and then processed these aliquots to generate fecal extracts for enhanced chemiluminescent Western immunoblot analysis as originally described. The authors have provided a corrected version of Fig 4 here.
The authors state that the data as they were reported in the original paper are correct, that the repeat Western blots confirm the presence of SIVcpz antibodies in samples MR1349 and MR1343, and not in any of the other eleven chimpanzee fecal samples, but that in contrast to , plasma from the same HIV-1 infected subject shown as the positive control (pos) in Figure 4 , but used at a 1:10,000,000 dilution; Chimp pos 10
, plasma from a captive chimpanzee experimentally infected with HIV-1 used at a 1:1,000,000 dilution (additional positive control); GM4522, fecal extract from an uninfected chimpanzee (additional negative control). (PDF)
